Lv4
780 积分 2022-04-20 加入
Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial
2天前
已完结
Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
2天前
待确认
Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
2天前
已关闭
The current status and optimization strategies of CAR-T cell therapy in hematological malignancies
3天前
已完结
CAR T cell combination therapies to treat cancer
6个月前
已完结
Chimeric antigen receptor T cell therapy for autoimmune disease
7个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
7个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
7个月前
已完结
Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia
11个月前
已完结
CD70 is a Potential Target Biomarker in Peripheral T‐cell Lymphomas
1年前
已完结
皖公网安备34019202002308
